Swiss pharma giant Novartis AG (NVS) is scheduled to post fourth-quarter 2023 results on Jan 31. The company has an impressive track record, beating the earnings expectations in each of the trailing four quarters. It delivered a four-quarter average earnings surprise of 6.99%. In the last reported quarter, it beat earnings estimates by 2.35%. Let's see how things are shaping up for this announcement. Factors Driving Growth With the successful spin-off of the Sandoz business in October 2023, Novartis operate ...